A novel inhibitor of BCL2, Disarib abrogates tumor growth while sparing platelets, by activating intrinsic pathway of apoptosis.
Biochem Pharmacol
; 122: 10-22, 2016 Dec 15.
Article
in En
| MEDLINE
| ID: mdl-27693384
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Thiadiazoles
/
Proto-Oncogene Proteins c-bcl-2
/
Indoles
/
Neoplasms
/
Antineoplastic Agents
Limits:
Animals
/
Humans
Language:
En
Year:
2016
Type:
Article